Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevnar 2 vs 3 Doses in Infants (MINOES)
NCT00189020Phase 3Completed
- Start
- Jun 2005
- Primary completion
- Feb 2008
- Modality
- Split/Subunit Vaccines
01
Overview
Phase 3, randomised, open-label trial of pneumococcal 7-valent conjugate vaccine in Streptococcus pneumoniae infection. Primary endpoint: Nasopharyngeal bacterial (pneumococcal) colonization at 24 months. Started Jun 2005; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
Streptococcus pneumoniae infection
Beyond the preview
Go deeper on NCT00189020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189020.